487 related articles for article (PubMed ID: 17277693)
21. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone.
Barcia E; Herrero-Vanrell R; Díez A; Alvarez-Santiago C; López I; Calonge M
Exp Eye Res; 2009 Aug; 89(2):238-45. PubMed ID: 19341729
[TBL] [Abstract][Full Text] [Related]
23. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of interleukin-18-loaded biodegradable microspheres.
Lagarce F; Garcion E; Faisant N; Thomas O; Kanaujia P; Menei P; Benoit JP
Int J Pharm; 2006 May; 314(2):179-88. PubMed ID: 16515850
[TBL] [Abstract][Full Text] [Related]
25. Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres.
Ito F; Makino K
Colloids Surf B Biointerfaces; 2004 Nov; 39(1-2):17-21. PubMed ID: 15542335
[TBL] [Abstract][Full Text] [Related]
26. Intralesional mitoxantrone biopolymer-mediated chemotherapy prolongs survival in rats with experimental brain tumors.
Saini M; Roser F; Hussein S; Samii M; Bellinzona M
J Neurooncol; 2004 Jul; 68(3):225-32. PubMed ID: 15332325
[TBL] [Abstract][Full Text] [Related]
27. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal assessment of regional directed delivery in a rodent malignant glioma model.
Kondo A; Goldman S; Lulla RR; Mania-Farnell B; Vanin EF; Sredni ST; Rajaram V; Soares MB; Tomita T
J Neurosurg Pediatr; 2009 Dec; 4(6):592-8. PubMed ID: 19951051
[TBL] [Abstract][Full Text] [Related]
29. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
30. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
31. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
32. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH
Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
34. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
35. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma.
Ranganath SH; Wang CH
Biomaterials; 2008 Jul; 29(20):2996-3003. PubMed ID: 18423584
[TBL] [Abstract][Full Text] [Related]
36. Drug delivery into the brain using poly(lactide-co-glycolide) microspheres.
Menei P; Montero-Menei C; Venier MC; Benoit JP
Expert Opin Drug Deliv; 2005 Mar; 2(2):363-76. PubMed ID: 16296760
[TBL] [Abstract][Full Text] [Related]
37. Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies.
Li KW; Dang W; Tyler BM; Troiano G; Tihan T; Brem H; Walter KA
Clin Cancer Res; 2003 Aug; 9(9):3441-7. PubMed ID: 12960135
[TBL] [Abstract][Full Text] [Related]
38. In vivo validation of biological responses of bFGF released from microspheres formulated by blending poly-lactide-co-glycolide and poly(ethylene glycol)-grafted-chitosan in hamster cheek pouch microcirculatory models.
Falabella CA; Jiang H; Frame MD; Chen W
J Biomater Sci Polym Ed; 2009; 20(7-8):903-22. PubMed ID: 19454159
[TBL] [Abstract][Full Text] [Related]
39. Visualization of the protective ability of a free radical trapping compound against rat C6 and F98 gliomas with diffusion tensor fiber tractography.
Asanuma T; Doblas S; Tesiram YA; Saunders D; Cranford R; Yasui H; Inanami O; Smith N; Floyd RA; Kotake Y; Towner RA
J Magn Reson Imaging; 2008 Sep; 28(3):574-87. PubMed ID: 18777527
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]